Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Taylor

Showing results (191-200 of 246) with videos related to

Pageof 25
Sort By:
BMJ Open|January 7, 2014
Temporal summation of pain and ultrasound Doppler activity as predictors of treatment response in patients with rheumatoid arthritis: protocol for the Frederiksberg hospitals Rheumatoid Arthritis, pain assessment and Medical Evaluation (FRAME-cohort) studyAnton Wulf Christensen, Signe Rifbjerg-Madsen, Robin Christensen, et al.
Annals of the Rheumatic Diseases|May 2, 2019
Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritisYoshiya Tanaka, Bruno Fautrel, Edward C Keystone, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 9, 2012
T2* measurement of the knee articular cartilage in osteoarthritis at 3TRexford D Newbould, Sam R Miller, Laurence D Toms, et al.
Annals of the Rheumatic Diseases|November 9, 2024
Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological studyJohannes Iuel Berg, Sabrina Mai Nielsen, Esben Malm, et al.
Scientific Reports|June 3, 2020
Novel biomarkers of a peripheral blood interferon signature associated with drug-naïve early arthritis patients distinguish persistent from self-limiting disease courseAttila A Seyhan, Bernard Gregory, Adam P Cribbs, et al.
Joint Bone Spine|June 9, 2026
Certolizumab Inhibits Radiographic Progression in Patients with Early Rheumatoid Arthritis and High Rheumatoid Factor Levels: A Pooled, Post‑Hoc Analysis of the Phase 3 C‑EARLY and C‑OPERA TrialsJosef S Smolen, Peter C Taylor, Gerd Burmester, et al.
JCI Insight|August 28, 2025
IL-23 drives uveitis by acting on a population of tissue-resident entheseal T cellsRobert Hedley, Amy Ward, Colin J Chu, et al.
European Radiology|January 25, 2017
Repeatability and response to therapy of dynamic contrast-enhanced magnetic resonance imaging biomarkers in rheumatoid arthritis in a large multicentre trial settingJohn C Waterton, Meilien Ho, Lars H Nordenmark, et al.
Patient Preference and Adherence|February 6, 2020
Treatment Mode Preferences in Rheumatoid Arthritis: Moving Toward Shared Decision-MakingPeter C Taylor, Neil Betteridge, T Michelle Brown, et al.
The Journal of Rheumatology|August 17, 2019
Patients with Rheumatoid Arthritis Acquire Sustainable Skills for Home Monitoring: A Prospective Dual-country Cohort Study (ELECTOR Clinical Trial I)Marie Skougaard, Henning Bliddal, Robin Christensen, et al.
Pageof 25

Showing results (191-200 of 246) with videos related to

Sort By:
Pageof 25
BMJ Open|January 7, 2014
Temporal summation of pain and ultrasound Doppler activity as predictors of treatment response in patients with rheumatoid arthritis: protocol for the Frederiksberg hospitals Rheumatoid Arthritis, pain assessment and Medical Evaluation (FRAME-cohort) studyAnton Wulf Christensen, Signe Rifbjerg-Madsen, Robin Christensen, et al.
Annals of the Rheumatic Diseases|May 2, 2019
Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritisYoshiya Tanaka, Bruno Fautrel, Edward C Keystone, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 9, 2012
T2* measurement of the knee articular cartilage in osteoarthritis at 3TRexford D Newbould, Sam R Miller, Laurence D Toms, et al.
Annals of the Rheumatic Diseases|November 9, 2024
Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological studyJohannes Iuel Berg, Sabrina Mai Nielsen, Esben Malm, et al.
Scientific Reports|June 3, 2020
Novel biomarkers of a peripheral blood interferon signature associated with drug-naïve early arthritis patients distinguish persistent from self-limiting disease courseAttila A Seyhan, Bernard Gregory, Adam P Cribbs, et al.
Joint Bone Spine|June 9, 2026
Certolizumab Inhibits Radiographic Progression in Patients with Early Rheumatoid Arthritis and High Rheumatoid Factor Levels: A Pooled, Post‑Hoc Analysis of the Phase 3 C‑EARLY and C‑OPERA TrialsJosef S Smolen, Peter C Taylor, Gerd Burmester, et al.
JCI Insight|August 28, 2025
IL-23 drives uveitis by acting on a population of tissue-resident entheseal T cellsRobert Hedley, Amy Ward, Colin J Chu, et al.
European Radiology|January 25, 2017
Repeatability and response to therapy of dynamic contrast-enhanced magnetic resonance imaging biomarkers in rheumatoid arthritis in a large multicentre trial settingJohn C Waterton, Meilien Ho, Lars H Nordenmark, et al.
Patient Preference and Adherence|February 6, 2020
Treatment Mode Preferences in Rheumatoid Arthritis: Moving Toward Shared Decision-MakingPeter C Taylor, Neil Betteridge, T Michelle Brown, et al.
The Journal of Rheumatology|August 17, 2019
Patients with Rheumatoid Arthritis Acquire Sustainable Skills for Home Monitoring: A Prospective Dual-country Cohort Study (ELECTOR Clinical Trial I)Marie Skougaard, Henning Bliddal, Robin Christensen, et al.
Pageof 25